Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mouradian, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mouradian, M. M.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrowRelated Articles
Neurology, Vol. 64, Issue 2, 182-183, January 25, 2005

EDITORIALS

Should levodopa be infused into the duodenum?

M. Maral Mouradian

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:


Related Articles

January 25 Highlights
Neurology 2005 64: 180-181. [Full Text] [PDF]

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
D. Nyholm, A. I.M. Nilsson Remahl, N. Dizdar, R. Constantinescu, B. Holmberg, R. Jansson, S. -M. Aquilonius, and H. Askmark
Neurology 2005 64: 216-223. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 NeurologyHome page
J. G. Nutt, D. Deleu, Y. Hanssens, D. Nyholm, R. Jansson, T. Willows, and I. N. Remahl
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Neurology, May 23, 2006; 66(10): 1611 - 1612.
[Full Text] [PDF]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mouradian, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mouradian, M. M.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrowRelated Articles